Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Multiplex, Droplet Digital PCR Assay for the Detection of T-Cell Receptor Excision Circles and Kappa-Deleting Recombination Excision Circles.

Profaizer T, Slev P.

Clin Chem. 2019 Oct 31. pii: clinchem.2019.308171. doi: 10.1373/clinchem.2019.308171. [Epub ahead of print]

PMID:
31672859
2.

Human Leukocyte Antigen Typing by Next-Generation Sequencing.

Profaizer T, Kumánovics A.

Clin Lab Med. 2018 Dec;38(4):565-578. doi: 10.1016/j.cll.2018.07.006. Epub 2018 Oct 5. Review.

PMID:
30420053
3.

HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: A comparison.

Profaizer T, Lázár-Molnár E, Pole A, Delgado JC, Kumánovics A.

Int J Immunogenet. 2017 Aug;44(4):164-168. doi: 10.1111/iji.12322. Epub 2017 May 28.

PMID:
28556460
4.

HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods.

Profaizer T, Lázár-Molnár E, Close DW, Delgado JC, Kumánovics A.

HLA. 2016 Jul;88(1-2):14-24. doi: 10.1111/tan.12850. Epub 2016 Aug 14.

PMID:
27524804
5.

Report on the effects of fragment size, indexing, and read length on HLA sequencing on the Illumina MiSeq.

Profaizer T, Coonrod EM, Delgado JC, Kumánovics A.

Hum Immunol. 2015 Dec;76(12):897-902. doi: 10.1016/j.humimm.2015.08.002. Epub 2015 Aug 22.

PMID:
26303189
6.

HLA alleles and drug hypersensitivity reactions.

Profaizer T, Eckels D.

Int J Immunogenet. 2012 Apr;39(2):99-105. doi: 10.1111/j.1744-313X.2011.01061.x. Epub 2011 Dec 3. Review.

PMID:
22136512
7.

Celiac disease and HLA typing using real-time PCR with melting curve analysis.

Profaizer T, Eckels D, Delgado JC.

Tissue Antigens. 2011 Jul;78(1):31-7. doi: 10.1111/j.1399-0039.2011.01676.x. Epub 2011 Apr 27.

PMID:
21521178
8.

Two-year reduction of panel reactive human leukocyte antigen antibodies in children receiving mycophenolate mofetil after valved allograft placement.

Anderson JB, Fuller TC, Hawkins JA, Brinkman MK, Profaizer T, Shaddy RE.

Transplantation. 2005 Aug 15;80(3):414-6.

PMID:
16082339
9.

Panel-reactive antibodies late after allograft implantation in children.

Hooper DK, Hawkins JA, Fuller TC, Profaizer T, Shaddy RE.

Ann Thorac Surg. 2005 Feb;79(2):641-4; discussion 645.

PMID:
15680851
10.

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation.

Shaddy RE, Fuller TC, Anderson JB, Lambert LM, Brinkman MK, Profaizer T, Hawkins JA.

Ann Thorac Surg. 2004 May;77(5):1734-9; discussion 1739.

PMID:
15111175
11.

Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts.

Hawkins JA, Hillman ND, Lambert LM, Jones J, Di Russo GB, Profaizer T, Fuller TC, Minich LL, Williams RV, Shaddy RE.

J Thorac Cardiovasc Surg. 2003 Jul;126(1):247-52; discussion 252-3.

12.

Prospective randomized trial of azathioprine in cryopreserved valved allografts in children.

Shaddy RE, Lambert LM, Fuller TC, Profaizer T, Thompson DD, Baker SI, Osborne KA, Hawkins JA.

Ann Thorac Surg. 2001 Jan;71(1):43-7; discussion 47-8.

PMID:
11216808
13.

A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery.

Breinholt JP 3rd, Hawkins JA, Lambert LM, Fuller TC, Profaizer T, Shaddy RE.

Circulation. 2000 Nov 7;102(19 Suppl 3):III179-82.

PMID:
11082383
14.

Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.

Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, Shaddy RE.

J Thorac Cardiovasc Surg. 2000 Feb;119(2):324-30.

15.

Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?

Fuller A, Profaizer T, Roberts L, Fuller TC.

Transplantation. 1999 Aug 27;68(4):589-91.

PMID:
10480424

Supplemental Content

Loading ...
Support Center